1. Home
  2. INUV vs MDXH Comparison

INUV vs MDXH Comparison

Compare INUV & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$0.96

Market Cap

24.2M

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.41

Market Cap

21.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INUV
MDXH
Founded
N/A
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Advertising
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
24.2M
21.1M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
INUV
MDXH
Price
$0.96
$0.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$11.00
$7.67
AVG Volume (30 Days)
293.8K
606.9K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
0.13
N/A
Revenue
$86,209,305.00
N/A
Revenue This Year
N/A
$30.78
Revenue Next Year
$12.89
$18.31
P/E Ratio
$8.00
N/A
Revenue Growth
2.88
N/A
52 Week Low
$0.95
$0.40
52 Week High
$5.63
$5.33

Technical Indicators

Market Signals
Indicator
INUV
MDXH
Relative Strength Index (RSI) 35.19 31.47
Support Level N/A N/A
Resistance Level $1.37 $3.79
Average True Range (ATR) 0.13 0.03
MACD -0.00 0.02
Stochastic Oscillator 6.05 5.41

Price Performance

Historical Comparison
INUV
MDXH

About INUV Inuvo Inc.

Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: